We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ENZ market cap is 59.18M. The company's latest EPS is USD 0.3943 and P/E is 2.89.
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.11M | -19.66M | 7.81M | 8.55M | 8.02M |
| Operating Income | -15.65M | 13.8M | -5.48M | -2.18M | -2.05M |
| Net Income | -15.19M | 57.43M | -6.62M | -3.06M | -3.02M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 110.1M | 76.02M | 117.73M | 107.07M | 31.06M |
| Operating Income | 1.73M | -30.37M | 692k | -15.01M | -24.74M |
| Net Income | 2.49M | -28.52M | 7.88M | -18.26M | 20.29M |
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 72.06M | 121.88M | 106.31M | 99.08M | 93.47M |
| Total Liabilities | 53.13M | 43.42M | 32.03M | 28.3M | 24.44M |
| Total Equity | 18.93M | 78.46M | 74.28M | 70.78M | 69.03M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.64M | 112.54M | 113.69M | 95.86M | 121.88M |
| Total Liabilities | 20.61M | 54.16M | 45.11M | 41.4M | 43.42M |
| Total Equity | 86.03M | 58.38M | 68.59M | 54.46M | 78.46M |
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.95M | -36.98M | -13.37M | -22.31M | -25.17M |
| Investing | -2.19M | 98.98M | -254k | -279k | -422k |
| Financing | 3.12M | -1.13M | -518k | -540k | -584k |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.81M | -17.18M | 387k | -16.59M | -36.98M |
| Investing | -8.13M | -2.17M | -34.5M | 25.22M | 98.98M |
| Financing | 4.19M | 7M | -242k | -241k | -1.13M |
| Market Cap | 59.18M |
| Price to Earnings Ratio | 2.89 |
| Price to Sales Ratio | 1.89 |
| Price to Cash Ratio | 0.71 |
| Price to Book Ratio | 0.75 |
| Dividend Yield | - |
| Shares Outstanding | 51.46M |
| Average Volume (1 week) | 64.46k |
| Average Volume (1 Month) | 110.94k |
| 52 Week Change | -20.14% |
| 52 Week High | 1.7099 |
| 52 Week Low | 0.9901 |
| Spread (Intraday) | 0.17 (14.17%) |
| Company Name | Enzo Biochem Inc |
| Address |
81 executive blvd. ste 3 farmingdale, new york 11735 |
| Website | https://www.enzo.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
